Nuvalent Company Leadership
| NUVL Stock | USD 77.02 0.01 0.01% |
Nuvalent's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Nuvalent suggests that most insiders are panicking. Nuvalent employs about 142 people. The company is managed by 11 executives with a total tenure of roughly 332 years, averaging almost 30.0 years of service per executive, having 12.91 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-02-24 | Matthew Shair | Disposed 2000 @ 78.43 | View | ||
| 2025-02-18 | James Richard Porter | Disposed 27000 @ 78.46 | View | ||
| 2025-01-27 | Matthew Shair | Disposed 2000 @ 82.79 | View | ||
| 2025-01-15 | James Richard Porter | Disposed 27000 @ 75.99 | View | ||
| 2025-01-06 | James Richard Porter | Disposed 17301 @ 79.68 | View | ||
| 2024-12-23 | Matthew Shair | Disposed 2000 @ 83.78 | View | ||
| 2024-12-16 | James Richard Porter | Disposed 27000 @ 86.61 | View | ||
| 2024-11-25 | Matthew Shair | Disposed 2000 @ 96.22 | View | ||
| 2024-10-31 | Alexandra Balcom | Disposed 10000 @ 89.19 | View | ||
| 2024-10-28 | Matthew Shair | Disposed 2000 @ 91.73 | View | ||
| 2024-10-22 | James E Flynn | Disposed 2000000 @ 97.75 | View | ||
| 2024-10-15 | James Richard Porter | Disposed 27000 @ 102.28 | View | ||
| 2024-10-01 | Darlene Noci | Disposed 5000 @ 101.74 | View | ||
| 2024-09-30 | Alexandra Balcom | Disposed 10000 @ 101.06 | View | ||
| 2024-09-23 | Matthew Shair | Disposed 2000 @ 102.75 | View | ||
| 2024-09-16 | Henry E Pelish | Disposed 32795 @ 98.92 | View | ||
| 2024-09-09 | Deborah Ann Miller | Disposed 3000 @ 88.18 | View | ||
| 2024-09-03 | Darlene Noci | Disposed 5000 @ 84.43 | View |
Monitoring Nuvalent's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Nuvalent |
Nuvalent Management Team Effectiveness
The company has return on total asset (ROA) of (0.187) % which means that it has lost $0.187 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2946) %, meaning that it created substantial loss on money invested by shareholders. Nuvalent's management efficiency ratios could be used to measure how well Nuvalent manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.24. Return On Capital Employed is expected to rise to -0.24 this year. At this time, Nuvalent's Debt To Assets are quite stable compared to the past year.The value of Common Stock Shares Outstanding is expected to slide to about 58.5 M. Net Loss is expected to rise to about (70 M) this year
Nuvalent Workforce Comparison
Nuvalent is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 4,994. Nuvalent holds roughly 142 in number of employees claiming about 2.84% of equities under Health Care industry.
Nuvalent Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvalent insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvalent's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nuvalent insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-03-01 | 0.4412 | 15 | 34 | 507,120 | 149,916 |
| 2024-12-01 | 0.3111 | 14 | 45 | 165,165 | 2,524,114 |
| 2024-09-01 | 0.1753 | 17 | 97 | 119,034 | 362,655 |
| 2024-06-01 | 0.4833 | 29 | 60 | 101,880 | 346,500 |
| 2024-03-01 | 0.6818 | 15 | 22 | 652,433 | 1,030,166 |
| 2023-12-01 | 0.3 | 12 | 40 | 147,041 | 514,082 |
| 2023-09-01 | 0.3889 | 14 | 36 | 67,330 | 134,660 |
| 2023-06-01 | 0.6216 | 23 | 37 | 184,767 | 69,534 |
| 2023-03-01 | 0.5882 | 10 | 17 | 1,009,580 | 42,300 |
| 2022-12-01 | 0.2564 | 10 | 39 | 865,821 | 242,296 |
| 2022-09-01 | 0.4286 | 3 | 7 | 68,404 | 24,332 |
| 2022-06-01 | 13.0 | 13 | 1 | 260,000 | 14,513 |
| 2022-03-01 | 4.5 | 9 | 2 | 831,400 | 8,400 |
| 2021-09-01 | 0.9444 | 17 | 18 | 20,232,638 | 100,043,254 |
Nuvalent Notable Stakeholders
A Nuvalent stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nuvalent often face trade-offs trying to please all of them. Nuvalent's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nuvalent's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James Porter | President CEO | Profile | |
| Darlene Noci | Chief Officer | Profile | |
| Matthew MBA | Senior Resources | Profile | |
| Perrin BS | Senior Strategy | Profile | |
| Prof Shair | Head Founder | Profile | |
| John Soglia | Senior Development | Profile | |
| Christopher MD | Chief Officer | Profile | |
| Deborah JD | Chief Secretary | Profile | |
| Benjamin Lane | Senior Operations | Profile | |
| Henry Pelish | Senior Discovery | Profile | |
| Matthew Metivier | Senior Resources | Profile |
About Nuvalent Management Performance
The success or failure of an entity such as Nuvalent often depends on how effective the management is. Nuvalent management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nuvalent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nuvalent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.23) | (0.24) | |
| Return On Capital Employed | (0.26) | (0.24) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.24) | (0.23) |
Nuvalent Workforce Analysis
Traditionally, organizations such as Nuvalent use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nuvalent within its industry.Nuvalent Manpower Efficiency
Return on Nuvalent Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 23.7M | |
| Working Capital Per Employee | 7.6M | |
| Working Capital Per Executive | 98M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.